Company: CI
Filing Date: 2025-05-02
Form Type: 10-Q
Source: 0001739940-25-000021
Chunk: 140

Company: Cigna Group
Filing Date: 2025-05-02
Form: 10-Q
Item: Part II, Item 4
Chunk 140
---
 December 31, 2024Federal government and agency$276 $— $14 $(9)$281 State and local government37 — 1 (1)37 Foreign government350 — 5 (11)344 Corporate9,091 (111)102 (659)8,423 Mortgage and other asset-backed371 — 1 (34)338 Total$10,125 $(111)$123 $(714)$9,423 

Review of Declines in Fair Value. Management reviews debt securities in an unrealized loss position to determine whether a credit loss allowance is needed based on criteria that include severity of decline; financial health and specific prospects of the issuer; and changes in the regulatory, economic or general market environment of the issuer's industry or geographic region.The table below summarizes debt securities with a decline in fair value from amortized cost for which an allowance for credit losses has not been recorded (by investment grade and the length of time these securities have been in an unrealized loss position). Unrealized depreciation on these debt securities is primarily due to declines in fair value resulting from increasing interest rates since these securities were purchased. March 31, 2025December 31, 2024(Dollars in millions)FairValueAmortizedCostUnrealizedDepreciationNumberof IssuesFairValueAmortizedCostUnrealizedDepreciationNumberof IssuesOne year or lessInvestment grade$567 $573 $(6)353$1,203 $1,227 $(24)545 Below investment grade220 228 (8)802245 250 (5)739 More than one yearInvestment grade3,818 4,319 (501)1,0804,687 5,319 (632)1,297 Below investment grade325 368 (43)107416 469 (53)123 Total$4,930 $5,488 $(558)2,342 $6,551 $7,265 $(714)2,704 

18

Equity SecuritiesThe following table provides the values of the Company's equity security investments: March 31, 2025 December 31, 2024(In millions) CostCarrying Value CostCarrying ValueEquity securities with readily determinable fair values$637 $38 $635 $37 Equity securities with no readily